Cohortias – Pros of Working with a CRO.

Sponsors may transfer any or all of their many tasks and obligations relating to clinical trials to Contract Research Organizations (CROs).
CRO

The Pros of Working With a CRO

Sponsors may transfer any or all of their many tasks and obligations relating to clinical trials to Contract Research Organizations (CROs). This ability to delegate through a Transfer of Regulatory Obligations (TORO) brings with it a range of advantages to the Sponsor. However, because the Sponsor is ultimately responsible, they must be aware of the drawbacks of giving a CRO so much responsibility.

The primary reason for outsourcing clinical trials to a CRO is that the Sponsor has limited internal resources. Working with a CRO gives a Sponsor instant access to virtually everything they need to conduct a successful clinical development program.

Here are some of the positive aspects of working with a CRO:

Sponsors can delegate all their duties and functions to a CRO

This is perhaps the most attractive aspect of working with a CRO. The ability to delegate all of a Sponsor’s duties and functions to a CRO means that the Sponsor can operate a drug development program when they otherwise might not be able to. This enables the Sponsor to leverage several other benefits that come with outsourcing clinical trials.

CROs have the necessary resources already in place

Clinical trials are complex exercises in project management, collaboration, and clinical patient care. To effectively conduct trials, Sponsors can rely on CROs because they already have the necessary resources in place. When tasked under a TORO, a CRO can be relied upon to manage all the responsibilities delegated to them, saving the Sponsor a significant amount of time and money.

CROs are prepared to move forward

Time is always of the essence with clinical trials. If a Sponsor needed to create or acquire everything required to run a clinical trial, the project would suffer significant delays. Because a CRO is set up to begin work when called upon, the amount of time it takes to get a trial up and running is reduced exponentially.

CROs have a global reach

In order to develop an application to market a drug in a country, the Sponsor must conduct a study in that country, which can be time and cost prohibitive for a Sponsor. However, a Sponsor can select a CRO that has research facilities and teams located across the globe, providing them with immediate access to the ability to market their drug in multiple countries.

CRO

Share:

More Posts

Send Us A Message